Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous remifentanil vs lidocaine for prevention of cardiovascular response to laryngeal mask airway insertion
IRCT20181229042169N1Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in None comparing Intravenous remifentanil with Intravenous lidocaine (2 arms). Primary endpoint: Cardiovascular response to laryngeal mask airway insertion. Started Aug 2020; status: completed.
02
Drugs
remifentanillidocaine
Beyond the preview
Go deeper on IRCT20181229042169N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181229042169N1.